Urology
Volume 75, Issue 5 , Page 1114, May 2010

Editorial Comment

Division of Hematology-Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0090-4295(09)02389-9

doi:10.1016/j.urology.2009.07.1290

Refers to article:

  • The Loss of Radiographic Enhancement in Primary Renal Cell Carcinoma Tumors Following Multitargeted Receptor Tyrosine Kinase Therapy is an Additional Indicator of Response , 20 November 2009

    C. Lance Cowey, Julia R. Fielding, W. Kimryn Rathmell
    Urology May 2010 (Vol. 75, Issue 5, Pages 1108-1113.e1)

Urology
Volume 75, Issue 5 , Page 1114, May 2010

Article Tools